Pfizer Inc Stock Widgets and Gadgets
PFE Stock | USD 27.78 0.19 0.69% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- PFE Pfizer Inc
- Latest Adobe Adds GenAI-Powered Workflow Planning to Content Supply Chain
- PFE 27.78 0.19
- Low 27.54
- High 27.94
- Volume 34.2 M
- Alpha -0.0909
- Beta 0.68
- Return On Equity 0.0235
- Return On Asset 0.0155
- Profit Margin 0.04 %
- Operating Margin (0.50) %
- Current Valuation 214.38 B
- Shares Outstanding 5.66 B
- Shares Owned By Insiders 0.04 %
- Shares Owned By Institutions 69.96 %
- Number Of Shares Shorted 66.12 M
- Price To Earning 9.48 X
- Price To Book 1.76 X
- Price To Sales 2.69 X
- Revenue 58.5 B
- Gross Profit 66.23 B
- EBITDA 10.53 B
- Net Income 2.13 B
- Cash And Equivalents 2.85 B
- Cash Per Share 6.44 X
- Total Debt 75.04 B
- Debt To Equity 0.40 %
- Current Ratio 1.59 X
- Book Value Per Share 15.77 X
- Cash Flow From Operations 8.7 B
- Short Ratio 1.53 X
- Earnings Per Share 0.37 X
- Price To Earnings To Growth 0.28 X
- Target Price 32.18
- Number Of Employees 88 K
- Beta 0.56
- Market Capitalization 157.22 B
- Total Asset 226.5 B
- Retained Earnings 118.35 B
- Working Capital (4.46 B)
- Current Asset 43.8 B
- Current Liabilities 29.4 B
- Z Score 2.38
- Annual Yield 0.06 %
- Five Year Return 3.60 %
- Net Asset 226.5 B
- Last Dividend Paid 1.64
- Accumulation Distribution 490053.0
- Daily Balance Of Power 0.475
- Rate Of Daily Change 1.01
- Day Median Price 27.74
- Day Typical Price 27.75
- Price Action Indicator 0.14
- Period Momentum Indicator 0.19
- Relative Strength Index 17.24
Market Snapshot Widget Example
DAX Index Germany | 18,477 0.50 | |
Taiwan Weighted Taiwan | 20,200 0.37 | |
PSI 20 Stock Portugal | 6,277 0.88 | |
CROBEX Croatia | 2,842 0.22 | |
Budapest SE Hungary | 64,830 0.27 | |
IDX 30 Jakarta Indonesia | 503.32 0.82 | |
ISEQ 20 Price Ireland | 1,642 0.89 | |
NYSE Comp USA | 18,255 1.09 | |
Tel Aviv 35 Israel | 2,005 0.34 | |
Coreshares Index Tracker South Afric | 1,046 0.38 | |
IPC MEXICO Mexico | 57,369 0.17 | |
KL Technology Malaysia | 64.31 0.42 | |
IBEX 35 Index Spain | 11,111 1.09 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,523 0.70 | |
SPASX Dividend Opportunities Australia | 1,668 0.31 | |
HNX 30 Vietnam | 532.84 0.75 | |
Bucharest BET-NG Romania | 1,206 0.37 | |
AMS Small Cap Netherlands | 1,217 0.32 | |
Oslo Exchange Mutual Norway | 1,280 0.47 | |
BEL Small Belgium | 9,225 0.4 | |
RTSI Index Russia | 1,128 1.15 | |
Basic Materials Brazil | 6,005 1.59 | |
Swiss Leader Price Switzerland | 1,919 0.23 | |
Athens General Comp Greece | 1,418 0.35 | |
Stock Exchange Of Thailand | 1,381 0.26 | |
PX Prague Stock Czech Repub | 1,490 0.07 | |
THE PHILIPPINE STOCK Philippines | 6,904 0.08 | |
WIG 30 Poland | 2,975 0.34 | |
BIST Electricity Turkey | 536.44 0.81 |
Investing Ideas
In addition to having Pfizer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Pfizer
Compare Pfizer To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Dividend Share 1.64 | Earnings Share 0.37 | Revenue Per Share 10.366 | Quarterly Revenue Growth (0.41) |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.